Ian Shakil - 15 Apr 2024 Form 4 Insider Report for Augmedix, Inc.

Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Apr 2024
Net transactions value
-$1,470
Form type
4
Filing time
16 Apr 2024, 21:07:21 UTC
Previous filing
15 Apr 2024
Next filing
19 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise $430 +500 +17% $0.8600 3,500 15 Apr 2024 Direct F1
transaction AUGX Common Stock Sale $1,900 -500 -14% $3.80 3,000 15 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -500 -0.11% $0.000000 455,949 15 Apr 2024 Common Stock 500 $0.8600 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan.
F2 Fully vested.